GB1523825A - Induction of ovulation with partially desialylated human chlorionic gonadotropin - Google Patents

Induction of ovulation with partially desialylated human chlorionic gonadotropin

Info

Publication number
GB1523825A
GB1523825A GB6259/76A GB625976A GB1523825A GB 1523825 A GB1523825 A GB 1523825A GB 6259/76 A GB6259/76 A GB 6259/76A GB 625976 A GB625976 A GB 625976A GB 1523825 A GB1523825 A GB 1523825A
Authority
GB
United Kingdom
Prior art keywords
ovulation
induction
partially desialylated
desialylated human
partially
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB6259/76A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Serono Laboratories Inc
Original Assignee
Serono Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Laboratories Inc filed Critical Serono Laboratories Inc
Publication of GB1523825A publication Critical patent/GB1523825A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/12—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

1523825 Partially desialylated human chorionic ganatotrophin SERONO LABORATORIES INC 17 Feb 1976 [17 Feb 1975] 06259/76 Heading A5B Pharmaceutical compositions for inducing ovulation and treating infertility in female animals comprise partially desialylated human chorionic gonadotrophin and a pharmaceutically acceptable carrier. The gonadotrophin is preferably desialylated to 15-35% (i.e. 15-35% of the total N-acetylneuraminic acid residues have been removed). The compositions are suitably in injectable form.
GB6259/76A 1975-02-17 1976-02-17 Induction of ovulation with partially desialylated human chlorionic gonadotropin Expired GB1523825A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48202/75A IT1057895B (en) 1975-02-17 1975-02-17 HUMAN CHORIONIC GONADOTROPINE PARALLEL DESALINIZED TO INDUCE OUVULATION

Publications (1)

Publication Number Publication Date
GB1523825A true GB1523825A (en) 1978-09-06

Family

ID=11265181

Family Applications (1)

Application Number Title Priority Date Filing Date
GB6259/76A Expired GB1523825A (en) 1975-02-17 1976-02-17 Induction of ovulation with partially desialylated human chlorionic gonadotropin

Country Status (8)

Country Link
US (1) US4062942A (en)
BE (1) BE838657A (en)
CA (1) CA1059030A (en)
DE (1) DE2606309C3 (en)
FR (1) FR2300573A1 (en)
GB (1) GB1523825A (en)
IL (1) IL49054A (en)
IT (1) IT1057895B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196123A (en) * 1978-11-20 1980-04-01 Eugenia Rosemberg Hybrid chorionic gonadotropin preparations and methods for stimulating ovulation using same
US4589402A (en) * 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
US4970071A (en) * 1985-01-18 1990-11-13 Mcmichael John Immunotherapeutic methods and compositions employing antigens characteristic of non human malignant neoplasms
US4966753A (en) * 1987-08-18 1990-10-30 Molecular Rx, Inc. Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms
US5384132A (en) * 1990-03-20 1995-01-24 Akzo N.V. Stabilized gonadotropin containing preparations
US5270057A (en) * 1990-03-20 1993-12-14 Akzo N.V. Stabilized gonadotropin containing preparations
IE64738B1 (en) * 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations
US5416071A (en) * 1991-03-12 1995-05-16 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release containing epo and hyaluronic acid
EP0739352A1 (en) * 1994-01-20 1996-10-30 Akzo Nobel N.V. New composition of glycoprotein isoforms having follicle stimulating activity
DE60212425T2 (en) * 2001-10-22 2006-11-09 Applied Research Systems Ars Holding N.V. FSH COMPOSITIONS HAVING A HIGH SIALYLATION RATE AND THEIR USE FOR THE PREPARATION OF MEDICAMENTS
AU2005252636A1 (en) 2004-05-17 2005-12-22 The General Hospital Corporation Compositions comprising female germline stem cells and methods of use thereof
KR20070073879A (en) * 2004-10-07 2007-07-10 스템 셀 테라퓨틱스 코포레이션 Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds
EA201391523A1 (en) 2011-04-14 2014-03-31 Зе Дженерэл Хоспитэл Корпорейшн COMPOSITIONS AND METHODS FOR ENERGY TRANSFER MITOCHONDRIA OF AUTOLOGICAL HERMINATIVE CELLS
AU2012276038B2 (en) 2011-06-29 2017-08-31 President And Fellows Of Harvard College Compositions and methods for enhancing bioenergetic status in female germ cells

Also Published As

Publication number Publication date
CA1059030A (en) 1979-07-24
FR2300573B1 (en) 1979-03-23
US4062942A (en) 1977-12-13
DE2606309A1 (en) 1976-08-26
IL49054A0 (en) 1976-04-30
DE2606309C3 (en) 1981-01-22
IT1057895B (en) 1982-03-30
BE838657A (en) 1976-08-17
IL49054A (en) 1979-09-30
DE2606309B2 (en) 1980-05-14
FR2300573A1 (en) 1976-09-10

Similar Documents

Publication Publication Date Title
GB1523825A (en) Induction of ovulation with partially desialylated human chlorionic gonadotropin
Jones Jr et al. The importance of the follicular phase to success and failure in in vitro fertilization
AU1025988A (en) Pharmaceutical composition of follicle stimulating hormone and luteinizing hormone
DE3583081D1 (en) IN VITRO FERTILITY.
NZ223598A (en) Zinc-protamine-alpha interferon complexes and pharmaceutical compositions
PH11557A (en) Amino acid formulations for patients with liver disease and method of using same
NL300049I2 (en) Production of heterodimeric human fertility hormone.
Beck et al. Oestrous synchronization in ewes: the effect of combining a prostaglandin analogue with a 5-day progestagen treatment
Kinzey et al. Maintenance of Pregnancy in Protein-Deficient Rats with Short-Term Injections of Ovarian Hormones.
ZA774835B (en) Unsaturated derivatives of 7-acylamido-3-cephem-4-carboxylic acid and process for their preparation
DE2966939D1 (en) Chorionic gonadotropin preparations and methods for using same
SIMPSON et al. Induction of ovulation with human urinary gonadotrophins in the monkey
ATE65407T1 (en) METHOD OF INDUCING OVULATION.
COUTINHO et al. Effects of gonadotropins on motility of human ovary
KR890008171A (en) Peptide constructs, immunogens containing them and their use in inhibiting fertility
Jaques Jr et al. THE INFLUENCE OF OESTROGEN ADMINISTRATION IN VIVO ON IN VITRO PROLACTIN RELEASE: Interaction between dopamine and ihyrolrophin releasing hormone
PT80214B (en) Process for the preparation of a pharmaceutical composition containing 9alpha,11beta-dichloro 16alpha-methyl 21-oxycarbonyldicyclohexyl-methyloxi-pregne-1,4-diene 3,20-dione as active agent and an inert product as excipient appropriate to permit r said composition to be used in the rectum or colon
O'Keane et al. Endocrine response to selective embryocide in a gonadotropin-induced quintuplet pregnancy
EP0310288A3 (en) Improved ovulation treatment
DE3751602T2 (en) Subcutaneous administration of human chorionic gonadotropin.
IE33484L (en) Increasing pregnancy rate in cows
GB2009177A (en) Amino-and guanidino -1,2,3,4 - tetrahydro -unaphtoic acid esters process for their preparation and pharmaceutical compositions containing them
Wei-Irenberg et al. Effect of intrauterine and intramuscular administration of human chorionic gonadotropin on corpus luteum function in cyclic rhesus monkeys
Josimovich et al. Vaginal Mucification Induced by Pituitary Prolactin and Placental Lactogen in Mice
Varley et al. The use of allyl-trenbolone or a combination of PMSG and HCG to control oestrus and ovulation in groups of peri-pubertal gilts

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PE20 Patent expired after termination of 20 years

Effective date: 19960216